Picard Medical Inc (PMI)

Picard Medical Inc. is a healthcare equipment and supplies company focused on medical device development, manufacturing, and commercialization. Through its subsidiaries, the company designs, produces, markets, and sells device products, including SynCardia TAH, an artificial heart intended for patients with advanced heart failure when the human heart has failed. Picard Medical operates in the United States, Europe, and other international markets. The company was incorporated in 2021 and is based in Tucson, Arizona. Picard Medical operates as a subsidiary of Hunniwell Picard I, LLC, and its common stock is listed on the NYSE under the ticker PMI.


Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Overall Financial Health Dividend Yield Next Earnings Date Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Free Cash Flow / Net Income
NYSE-PMI
$7.49
47.4% Upside
Undervalued
Not available
Not available
Fair
0.0%
November 13, 2026
6.9x
1.9x
11.88 M
13.42 M
10.8%
54.8%
-20.1
60.8%
Valuation • Fair Value

Picard Medical Inc (NYSE-PMI) Fair Value by Valuation Model

Review the available estimates for Picard Medical Inc (NYSE-PMI), including DCF Fair Value, Comps Fair Value.

Primary Valuation Read

Fair Value

$7.49

Estimated upside of 47.4% versus the current market price.

Fair Value Confidence

Very low

Confidence level for the primary fair value estimate.

DCF Fair Value

$9.66

Discounted cash flow valuation reference.

Comps Fair Value

$7.05

Comparable-company valuation reference.

Analyst Price Target

Not available

Data is currently unavailable.

How to read these valuation models

Use the 4 available valuation references for Picard Medical Inc (NYSE-PMI) as analytical inputs, not a standalone conclusion. Valuation methods can differ because they rely on different assumptions, time horizons and financial inputs; compare the estimates with the current price and the company’s financial quality.

Profitability • Growth

Profitability & Growth for Picard Medical Inc (NYSE-PMI)

Review the profitability and growth indicators currently supported by the latest data.

Revenue

6.3 M

Current operating scale indicator.

Revenue Forecast

5.5 M

Forward revenue estimate.

EBITDA

-15.458 M

Current operating profitability reference.

How to read profitability and growth

This section helps investors review Picard Medical Inc (NYSE-PMI) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Picard Medical Inc (NYSE-PMI)

Review the financial quality and risk indicators currently supported by the latest data.

Financial Health

Fair

Mixed or neutral financial-health read.

Piotroski Score

5

Mid-range quality score.

Beneish M-Score

-8.88

No elevated caution signal from this screen.

Altman Z-Score

-20.1

Lower score that deserves closer risk review.

FCF / Net Income

60.8%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Picard Medical Inc (NYSE-PMI). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Picard Medical Inc (NYSE-PMI)

Track the upcoming dates and dividend metrics currently supported by the latest data.

Next Earnings Date

November 13, 2026

Days to Earnings

56

Dividend Yield

0.0%

No current dividend yield is indicated.

How to read events and dividends

This section helps investors track time-sensitive items for Picard Medical Inc (NYSE-PMI), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

Picard Medical Inc (NYSE-PMI) Stock Forecast & Technical Outlook

Review Picard Medical Inc (NYSE-PMI) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Sell

The 15-minute technical read for Picard Medical Inc (NYSE-PMI) is currently Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Sell

The 1-hour technical read for Picard Medical Inc (NYSE-PMI) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Sell

The daily technical read for Picard Medical Inc (NYSE-PMI) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Sell

The weekly technical read for Picard Medical Inc (NYSE-PMI) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Sell

The monthly technical read for Picard Medical Inc (NYSE-PMI) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for Picard Medical Inc (NYSE-PMI)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Hold

Based on the available recommendation mix, Picard Medical Inc (NYSE-PMI) has a Hold consensus, with 0 buy, 1 hold and 0 sell recommendations in the current data set.

Buy 0
Hold 1
Sell 0
FAQ Fast Investor Answers

Picard Medical Inc (NYSE-PMI) Stock FAQ

Data-supported answers about Picard Medical Inc (NYSE-PMI), including explicit coverage status where a reliable valuation estimate is not currently available.

Fair Value
$7.49
Estimated upside 47.4%
Valuation Rating
Undervalued
Estimated upside of 47.4%
Financial Health
Fair
Current financial-health read

The current fair value estimate for Picard Medical Inc (NYSE-PMI) is $7.49. This implies an estimated upside of 47.4% versus the current market price.

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 47.4% versus the current market price.

The current financial health read for Picard Medical Inc (NYSE-PMI) is Fair. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Picard Medical Inc (NYSE-PMI) is November 13, 2026.

The latest available data indicates no current dividend yield for Picard Medical Inc (NYSE-PMI).

The current market capitalization listed for Picard Medical Inc is 11.88 M.

The current enterprise value listed for Picard Medical Inc is 13.42 M. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Picard Medical Inc is NYSE-PMI, and the stock is listed on NYSE.

Picard Medical Inc (NYSE-PMI) is listed on NYSE.

The current debt-to-total-capital ratio listed for Picard Medical Inc is 10.8%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Picard Medical Inc is 54.8%. Free float helps investors understand how much of the share base is available for public trading.